High dose vitamin B1 supplementation may slow the progression of Alzheimer’s disease.
A large scale clinical trial is now underway to test this hypothesis. The study is using a synthetic fat-soluble form of vitamin B1 (benfotiamine), which the researchers believe will better penetrate into the brain than ordinary thiamine.
▶
